Alterity Therapeutics (ATHE) Competitors $5.00 +0.39 (+8.46%) Closing price 04:00 PM EasternExtended Trading$4.84 -0.16 (-3.10%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATHE vs. THTX, BDTX, ALTS, LYEL, IKT, SKYE, GALT, GLSI, RAPT, and NMRAShould you be buying Alterity Therapeutics stock or one of its competitors? The main competitors of Alterity Therapeutics include Theratechnologies (THTX), Black Diamond Therapeutics (BDTX), ALT5 Sigma (ALTS), Lyell Immunopharma (LYEL), Inhibikase Therapeutics (IKT), Skye Bioscience (SKYE), Galectin Therapeutics (GALT), Greenwich LifeSciences (GLSI), Rapt Therapeutics (RAPT), and Neumora Therapeutics (NMRA). These companies are all part of the "pharmaceutical products" industry. Alterity Therapeutics vs. Its Competitors Theratechnologies Black Diamond Therapeutics ALT5 Sigma Lyell Immunopharma Inhibikase Therapeutics Skye Bioscience Galectin Therapeutics Greenwich LifeSciences Rapt Therapeutics Neumora Therapeutics Alterity Therapeutics (NASDAQ:ATHE) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability. Do institutionals and insiders have more ownership in ATHE or THTX? 2.1% of Alterity Therapeutics shares are owned by institutional investors. 38.8% of Alterity Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger earnings & valuation, ATHE or THTX? Theratechnologies has higher revenue and earnings than Alterity Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlterity TherapeuticsN/AN/A-$12.54MN/AN/ATheratechnologies$85.87M1.68-$8.31M-$0.19-16.53 Which has more risk & volatility, ATHE or THTX? Alterity Therapeutics has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Is ATHE or THTX more profitable? Alterity Therapeutics has a net margin of 0.00% compared to Theratechnologies' net margin of -10.85%. Company Net Margins Return on Equity Return on Assets Alterity TherapeuticsN/A N/A N/A Theratechnologies -10.85%N/A -9.83% Does the media refer more to ATHE or THTX? In the previous week, Theratechnologies' average media sentiment score of 1.87 beat Alterity Therapeutics' score of 0.93 indicating that Theratechnologies is being referred to more favorably in the news media. Company Overall Sentiment Alterity Therapeutics Positive Theratechnologies Very Positive Do analysts prefer ATHE or THTX? Alterity Therapeutics currently has a consensus target price of $12.00, suggesting a potential upside of 140.00%. Given Alterity Therapeutics' higher probable upside, analysts plainly believe Alterity Therapeutics is more favorable than Theratechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alterity Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Theratechnologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryAlterity Therapeutics beats Theratechnologies on 7 of the 12 factors compared between the two stocks. Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATHE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATHE vs. The Competition Export to ExcelMetricAlterity TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$40.88M$2.91B$5.52B$9.41BDividend YieldN/A2.45%3.80%4.04%P/E RatioN/A19.8828.0419.84Price / SalesN/A305.11429.5399.59Price / CashN/A43.1635.8457.94Price / Book4.817.678.125.65Net Income-$12.54M-$55.28M$3.25B$258.00M7 Day Performance8.93%2.50%0.97%2.09%1 Month Performance15.21%11.70%7.36%11.13%1 Year Performance163.16%4.89%31.31%18.40% Alterity Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATHEAlterity Therapeutics2.0227 of 5 stars$5.00+8.5%$12.00+140.0%+115.4%$40.88MN/A0.0010Gap UpHigh Trading VolumeTHTXTheratechnologiesN/A$3.17-0.9%N/A+104.6%$147.14M$85.87M-39.63140Positive NewsHigh Trading VolumeBDTXBlack Diamond Therapeutics2.7146 of 5 stars$2.50-3.1%$12.80+412.0%-46.1%$146.71MN/A41.6790Positive NewsALTSALT5 Sigma0.086 of 5 stars$7.54-8.4%N/AN/A$143.65M$12.53M0.00170LYELLyell Immunopharma3.1418 of 5 stars$9.15-5.6%$15.00+63.9%-73.0%$143.49M$60K-0.37270IKTInhibikase Therapeutics1.2171 of 5 stars$1.93+2.1%$6.50+236.8%+27.5%$143.48MN/A-0.726SKYESkye Bioscience2.2344 of 5 stars$4.39-4.8%$16.60+278.1%-41.0%$142.80MN/A-5.3511GALTGalectin Therapeutics2.1154 of 5 stars$2.15-1.4%$6.00+179.1%+12.2%$137.98MN/A-2.999GLSIGreenwich LifeSciences2.1832 of 5 stars$10.07+0.4%$39.00+287.3%-24.2%$134.08MN/A-7.993Positive NewsRAPTRapt Therapeutics4.2022 of 5 stars$8.16+1.4%$24.00+194.1%-64.8%$133.12M$1.53M-0.4280NMRANeumora Therapeutics2.3949 of 5 stars$0.90+9.0%$7.50+737.7%-85.6%$132.89MN/A-0.56108Positive NewsAnalyst ForecastGap Up Related Companies and Tools Related Companies THTX Competitors BDTX Competitors ALTS Competitors LYEL Competitors IKT Competitors SKYE Competitors GALT Competitors GLSI Competitors RAPT Competitors NMRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATHE) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHE Stock Alerts